FV

Fonds Vives II (University of Louvain, UCL)

Description

Fonds Vives II (University of Louvain, UCL)

Investor Profile

Fonds Vives II (University of Louvain, UCL) has backed more than 5 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Seed rounds (top funding stages).
  • Majority of deals are located in Belgium, United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Seed (20%)

Country Focus

  • Belgium (60%)
  • United States (40%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Health Diagnostics
  • Home Health Care
  • Lifestyle
  • Medical Device
  • Wellness
  • Biopharma
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fonds Vives II (University of Louvain, UCL) frequently co-invest with?

HBM Partners
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 1
Fund+
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 2
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
6 Dimensions Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 2
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 2
CV
North America, Texas, United States, Dallas
Co-Investments: 1

Which angels does Fonds Vives II (University of Louvain, UCL) often collaborate with?

PD
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Shared Deals: 1

What are some of recent deals done by Fonds Vives II (University of Louvain, UCL)?

Sunrise

Brussels, Brussels Hoofdstedelijk Gewest, Belgium

We are a virtual sleep clinic, using our own 3-gram sensor to diagnose sleep with gold standard quality.

Health CareHealth DiagnosticsHome Health CareLifestyleMedical DeviceWellness
SeedDec 15, 2021
Amount Raised: $7,338,604
Virovet

Leuven, Vlaams-Brabant, Belgium

ViroVet is a pioneering company.

BiotechnologyPharmaceuticalVeterinary
Series BMay 28, 2020
Amount Raised: $6,647,249
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series BJun 20, 2018
Amount Raised: $75,000,000
A-Mansia Biotech

Louvain-la-neuve, Vlaams-Brabant, Belgium

A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium.

BiopharmaBiotechnologyLife Science
Series AApr 27, 2018
Amount Raised: $15,790,497
ITeos Therapeutics

Cambridge, Massachusetts, United States

ITeos Therapeutics is a biotechnology company that specializes in tumor immunology, cancer immunotherapy, and drug discovery.

BiotechnologyHealth CareMedical
Series AMay 3, 2012
Amount Raised: $11,830,415

Find More Investors Like Fonds Vives II (University of Louvain, UCL)

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Fonds Vives II (University of Louvain, UCL) | Pipeseed